Clearbridge Investments LLC Boosts Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Clearbridge Investments LLC grew its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 198,058 shares of the company’s stock after acquiring an additional 1,511 shares during the period. Clearbridge Investments LLC’s holdings in Acadia Healthcare were worth $15,401,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ACHC. Sivik Global Healthcare LLC lifted its holdings in Acadia Healthcare by 25.0% in the third quarter. Sivik Global Healthcare LLC now owns 75,000 shares of the company’s stock valued at $5,273,000 after acquiring an additional 15,000 shares during the period. Arizona State Retirement System raised its holdings in shares of Acadia Healthcare by 1.3% in the 3rd quarter. Arizona State Retirement System now owns 26,205 shares of the company’s stock valued at $1,842,000 after purchasing an additional 349 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Acadia Healthcare in the 3rd quarter valued at about $704,000. Great Lakes Advisors LLC increased its stake in Acadia Healthcare by 2.9% in the 3rd quarter. Great Lakes Advisors LLC now owns 49,817 shares of the company’s stock valued at $3,503,000 after buying an additional 1,396 shares during the period. Finally, Oppenheimer & Co. Inc. purchased a new position in Acadia Healthcare during the 3rd quarter worth $390,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research report on Wednesday. Barclays decreased their price target on Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 15th. UBS Group raised their target price on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. TD Cowen lowered their price target on shares of Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating on the stock in a research note on Friday, May 17th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective on the stock in a report on Thursday, April 25th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $87.56.

Insiders Place Their Bets

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available at this link. 2.00% of the stock is currently owned by insiders.

Acadia Healthcare Price Performance

NASDAQ:ACHC traded down $0.67 during trading hours on Friday, reaching $63.58. 649,725 shares of the company traded hands, compared to its average volume of 1,132,506. Acadia Healthcare Company, Inc. has a 1-year low of $63.10 and a 1-year high of $87.77. The firm’s 50-day moving average is $72.26 and its 200-day moving average is $76.82. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period last year, the company earned $0.75 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.53 EPS for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.